Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 476
Immune Disorders Drugs 202
Drug Discovery 170
Cardiovascular Drugs 157
Infectious Diseases Drugs 135
Biopharmaceuticals 130
Clinical Trials 125
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 85
Hematological Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 62
Diabetes Drugs 55
Dermatological Drugs 55
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 42
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Drug Delivery 37
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 32
Infusions and Injectables 30
Liver Cancer Drugs 28
Analgesics 25
Drugs by Therapeutic Area 24
Bladder Cancer Drugs 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Schizophrenia Drugs 19
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Breast Cancer Drugs 14
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Alzheimer's Disease Drugs 8
Optical Disorders Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

2,452 Results (Page 62 of 123)
- Relevance
  Sort by

Antibody Therapeutics Market by Format (Monoclonal, Polyclonal, Antibody Fragment, Bispecific), Disease Area (Oncology, Autoimmune & Inflammatory, Neurology, Hematology, Infectious), Source (Human, Chimeric), Route (IV, SC) and Region - Forecast to 2028

 Report
December 2023
307 Pages
Global

From

€4517EUR$4,950USD£3,852GBP

Drug Manufacturing Sector Scorecard - Thematic Intelligence

 Report
October 2022
23 Pages
Global

From

€1780EUR$1,950USD£1,517GBP

Non-Hodgkin Lymphoma Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

 Report
February 2024
130 Pages
Global

From

€4107EUR$4,500USD£3,502GBP

Meglitinide Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

 Report
August 2023
80 Pages
Global

From

€4335EUR$4,750USD£3,696GBP

Cutaneous T-Cell Lymphoma Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
114 Pages
Global

From

€4335EUR$4,750USD£3,696GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Hodgkin Lymphoma Treatment Market - Growth, Trends and Forecasts (2023 - 2028)

 Report
April 2023
110 Pages
Global

From

€4335EUR$4,750USD£3,696GBP

T-Cell Lymphoma Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

 Report
April 2025
182 Pages
Global

From

€4107EUR$4,500USD£3,502GBP

Human Reproductive Technologies: Products and Global Markets

 Report
July 2022
193 Pages
Global

From

€5019EUR$5,500USD£4,280GBP

Ewing Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
204 Pages
Global

From

€1825EUR$2,000USD£1,556GBP

Kaposi Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
94 Pages
Global

From

€1825EUR$2,000USD£1,556GBP

Gallbladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
195 Pages
Global

From

€1825EUR$2,000USD£1,556GBP

Lymphoma Therapeutics Market By Disease Type, By Treatment Type, By Route of Administration, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032

 Report
April 2023
481 Pages
Global

From

€2357EUR$2,583USD£2,010GBP

€3368EUR$3,690USD£2,871GBP

B-Cell Non-Hodgkin Lymphoma - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€7255EUR$7,950USD£6,186GBP

Diffuse Large B-Cell Lymphoma - Pipeline Insight, 2024

 Clinical Trials
June 2024
240 Pages
Global

From

€2738EUR$3,000USD£2,335GBP

Follicular Lymphoma - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€7255EUR$7,950USD£6,186GBP

Autoinjectors Market by Usage (Disposable, Reusable), Technology (Manual, Automatic), Therapy (Rheumatoid Arthritis, Diabetes, Obesity, Anaphypaxis, Multiple Sclerosis), Route of Administration (SC, IM), Volume (<3ml, >3ml) - Global Forecast to 2030

 Report
March 2025
384 Pages
Global

From

€4517EUR$4,950USD£3,852GBP

Triple Negative Breast Cancer Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
November 2023
224 Pages
Global

€4559EUR$4,995USD£3,887GBP

Autism - Global Clinical Trials Review, 2022

 Clinical Trials
January 2022
419 Pages
Global

From

€2282EUR$2,500USD£1,945GBP

Diffuse Large B-cell Lymphoma Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
March 2025
183 Pages
Global

From

€4107EUR$4,500USD£3,502GBP

Acute Myeloid Leukemia (AML) - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€7255EUR$7,950USD£6,186GBP

2,452 Results (Page 62 of 123)
- 1
- 60
- 61
- 62
- 63
- 64

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.